After almost two years, the end of the COVID-19 pandemic is finally at hand in the US. That’s according to former FDA commissioner and Pfizer board member Dr. Scott Gottlieb. During an appearance Friday on CNBC’s morning program Squawk Box, Gottlieb shared his prediction for when COVID will end here. Meaning, when the pandemic will …
Earlier this week, the FDA announced that Pfizer was voluntarily recalling all lots of Chantix 0.5mg and 1mg tablets. The drug recall is due to the presence of N-nitroso-varenicline. In large enough quantities, N-nitroso-varenicline can be a carcinogen. If this recall sounds at all familiar, it’s because Pfizer back in August issued a similar recall …
Over the past few days, Pfizer started recalling an increasing number of lots of Chantix, a prescription medication designed to help people stop smoking. The batches are being recalled due to the presence of N-nitroso-varenicline. N-nitroso-varenicline is a carcinogen when consumed in excess quantities. Still, the risk to adults on the medication appears to be …
Health officials involved in coronavirus vaccine clinical trials said that the drugs weren’t designed to stop the spread of COVID-19. The goal was to prevent severe COVID-19 cases and deaths. Preventing infection would be a welcome side effect. That meant vaccinated individuals could potentially still get infected, and they could still infect others, even though …
As more contagious COVID variants spread across the US, Pfizer is exploring the utility of a third booster dose. Pfizer hopes that a third vaccine dose might “raise the antibody response 10 to 20 fold.” Pfizer and Moderna are planning to boost vaccine production and ship 140 million doses to the US over the next …
A study that included 1.2 million people in Israel, half of which were fully vaccinated with the Pfizer/BioNTech drug, shows the vaccine is highly effective at preventing severe COVID-19. The researchers also learned that the vaccine offers excellent protection against severe COVID-19, hospitalization, and death — even after just one dose. The study was conducted …
Pfizer and BioNTech announced a significant change to their coronavirus vaccine that could have a dramatic impact on shipping logistics and vaccine availability. The two companies say the drug can be stored at higher temperatures, which makes it easier to transport and should extend the vaccine’s reach. Pfizer and BioNTech say the vaccine can be …
Pfizer says that coronavirus vaccine output will be greatly improved as the company has increased manufacturing efficiency. The company has reduced the time it takes to manufacture a batch of COVID-19 vaccines to 60 days from the initial 110-day average. Pfizer has also increased output at its three US-based plants involved in the vaccine manufacturing …
Pfizer is planning to deliver 200 million COVID vaccine doses to the US by May. Pfizer has managed to ramp up vaccine production significantly in recent weeks. Early on, Pfizer didn’t think it would be able to deliver 200 million vaccine doses until July 31. President Biden has promised that all Americans will have access …
A study from Israel indicates that people who received the Pfizer/BioNTech coronavirus vaccine develop an immune response significantly stronger than COVID-19 survivors. These researchers think this sort of immunity might completely prevent COVID-19 transmission, although more data is needed to prove that’s the case. The goal of current COVID-19 vaccines is to prevent severe illness …
